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ABSTRACT  
Background: Target organ damage takes place early in course of hypertension. But, despite this, the disease remains inadequately 
controlled in majority of patients partly because of its asymptomatic nature. With incidence of hypertension on the rise, there have not 
been adequate studies in our country linking hypertensive target organ damage with microalbuminuria and creatinine clearance especially 
in asymptomatic patients. Aims: To find the relationship between microalbuminuria and reduced creatinine clearance with subclinical 
target organ damage in asymptomatic primary hypertensive patients. Material & Methods: 60 hypertensive patients were evaluated for 
mild renal dysfunction defined as 24 hour urine albumin(UA) > 30 mg/d and/or Creatinine Clearance (CCR) < 60 ml/min/1.73m2 .Target 
organ damage evaluated were retinopathy (direct fundoscopy) and Left ventricular hypertrophy (2D ECHO). Results: There was 
significant association between microalbuminuria (30 %) and reduced creatinine clearance (38%) with target organ damage i.e. left 
ventricular hypertrophy [p < 0.001 & p 0.001 respectively] and hypertensive retinopathy [p 0.005 & p 0.03 respectively]. Patients with 
urine microalbumin had 30 times risk [95% CI: 3.6-253,p 0.001] and those with reduced creatinine clearance had 5.9 times the risk [95% 
CI: 1.7-19.4, p 0.0035] of developing target organ damage. But when present together the risk increased to 39.4 times [95% CI: 2.2-703, 
p 0.0124]. Conclusions: Results show that a reduction in creatinine clearance and/or presence of microalbuminuria is a marker of 
subclinical organ damage in patients with primary hypertension. Microalbuminuria showed better association with target organ damage 
than reduced creatinine clearance. 
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INTRODUCTION 
Hypertension is a major public health problem in India and in 
other developing countries. HTN is directly responsible for 57% 
of all stroke deaths and 24% of all coronary heart disease (CHD) 
deaths in India.[1] In India, the prevalence is 22% – 45% among 
men and about 16% – 38% among women.[2] 
Target organ damage due to hypertension results in adverse 
prognostic significance irrespectively of whether it involves the 
structure and/or function of the heart, brain, kidney, or 
vessels.[3]Studies have shown when organ damage is present, 
patients usually have a high total cardiovascular (CV) risk [4] i.e., 
a chance of having a morbid or fatal CV event within 10 years 
>20%. 
The kidney has a dual role in primary hypertension. On the one 
hand, it is the cause of elevated blood pressure and on the other 
it may suffer from the long-term negative consequences of the 
hypertensive state. As renal function has shown to be inversely 
related to the occurrence of cardiovascular events, it may serve 
as a sensor of cardiovascular risk. [5] 
Mild renal dysfunction( UA > 30mg/d and/or CCR <60ml/min) 
is a common finding in patients with hypertension and is 
associated with an increased risk for cardiovascular events as 
well as progression to end-stage renal disease.[6,7] This 
cardiovascular risk, progressively increases as renal function 
declines.[8]  
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Therefore, assessment of these subclinical target-organ damage 
represents an important aspect for the risk stratification of these 
hypertensive patients. This has led to the emergence of the 
concept “Global cardiovascular risk”. It is imperative that these 
changes of end organ damage be picked up early so as to identify 
patients who require more aggressive management. In this 
context, assessment of subclinical target organ damage has 
become a key aspect in evaluating and managing hypertensive 
patients. 
MATERIALS AND METHODS 
This was a case series study conducted in the department of 
internal medicine, S.Nijalingappa Medical College and HSK 
Hospital, Bagalkot, a tertiary care hospital. 60 subjects with a 
diagnosis of essential hypertension who were asymptomatic and 
aged between 30 – 60 years were included in the study from Jan 
1, 2013 to Dec 31, 2013. Previously diagnosed cases of 
secondary hypertension, Pregnancy,  Diabetes mellitus, Urinary 
tract infections, Renal disease (Serum Creatinine > 1.4 mg/dl for 
females and > 1.5 mg/dl for men), Presence of overt proteinuria 
[>300mg/d of albuminuria], Chronic heart failure, Positive 
history or clinical signs of ischemic heart disease and 
cerebrovascular disease.  Severe obesity (defined as body 
weight >150% of the ideal body weight or BMI > 40), 
Underweight (defined as BMI< 18.5) , Disabling diseases such 
as dementia or inability to co-operate, Patients already on 
angiotensin converting enzyme inhibitor drugs were excluded 
from the study. Institutional ethical committee clearance was 
obtained for the study and all patients participating in this study 
had given their informed written consent . 
A diagnosis of hypertension was confirmed from history. The 
duration of hypertension, treatment, history of smoking/ other 
habits, symptoms pertaining to cardiovascular, renal, peripheral 
vascular system, ocular and nervous system was meticulously 
asked for, which could suggest the possibly of a pre-existing 
target organ damage. BP was recorded with two readings taken 
with the patient sitting relaxed, back supported, for five minutes 
and arm supported at the level of heart. JNC 7 classification was 
used to stratify the severity of hypertension. All subjects 
underwent routine Blood and urinary examinations, 12 lead 
ECG, opthalmoscopic evaluation and 24 hour urinary albumin 
after a written consent. Subjects who had left ventricular 
hypertrophy (LVH) in ECG as per Sokolow - Lyon Index or the 
Romhilt - Estes point score system were confirmed with Two 
dimensional guided M-mode echocardiography. A Left 
ventricular mass index of more than 115 gms / m2 in men and 95 
gms / m2 in women were taken as the levels, above which LVH 
was be diagnosed as per EHC 2013 guidelines. Subjects were 
taken as having LVH only if they were positive for both ECG 
and echocardiography. Hypertensive retinopathy was evaluated 
by direct ophthalmoscopy and classified by Keith - Wagener - 
Barker system. Creatinine clearance was estimated by using the 
Cockcroft-Gault formula. This value was adjusted for body 
surface area (BSA). A creatinine clearance of less than 
60ml/min/1.73m2 was considered as reduced. 24 hour urine 
albumin was estimated using the Erba-Mannheim urinary 
albumin assay - an immunoturbidimetric, in vitro diagnostic 
assay for quantification of albumin in human urine by means of 
clinical chemistry analyzer. This method is done by 
measurement of antigen-antibody reaction by the end-point 
method. The patients were asked to avoid exercise or exertion 
prior to urine collection. In women, urine was collected during 
the non menstrual phase of their cycles. A value of 30-300 mg/d 
of albuminuria was considered as microalbuminuria. Target 
organ damage (TOD) was defined as the presence of LVH or 
Retinopathy or both. 
STATISTICAL ANALYSIS 
Statistical analysis was done with SPSS software and OPEN EPI 
version 2.3.1 Chi-square test to study the relationship between 
microalbuminuria, creatinine clearance and other variables. P 
value was calculated for all the variables and a value less than 
0.05 was considered significant. Unpaired Student ‘t’ test was 
used to analyse quantitative data. 
RESULTS 
The mean age group of the subjects were 50.15 ± 8.83 years with 
an average duration of hypertension of 6.68 ± 4.89 years. The 
mean 24 hour urine albumin of the population was 37.22 mg/d 
and creatinine clearance 79.58 ml/min. Of the 60 cases, 18 cases 
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were positive for urine microalbumin (30 %) and 23 cases (38 
%) had reduced creatinine clearance (Table 1). 
Microalbuminuria showed a statistically significant increase 
with age, duration of hypertension, systolic and diastolic BP, 
total cholesterol, Sr creatinine and reduced creatinine clearance 
when compared to patients who were normoalbuminuric. In 
patients who had a reduced creatinine clearance (<60 
ml/min/1.7m2) there was a statistically significant increase in 
age, duration of hypertension, Sr creatinine and 24 hr urine 
albumin when compared to patients who had creatinine 
clearance >60 ml/min/1.7m2. But, although there was increase 
in systolic BP, diastolic BP and total cholesterol in patients with 
reduced creatinine clearance they were found to be not 
statistically significant (p > 0.05).Both microalbuminuria and 
reduced creatinine clearance had a significant association with 
unfavourable lipid profile (<0.001). 
Table 1. General characteristics of Microalbuminuria and Reduced creatinine Clearance Groups. 
Table 2. Grades of Retinopathy in relation to Microalbuminuria and Creatinine Clearance 
 
Grades of 
Retinopathy 
 
 
Total no 
 
Microalbuminuria 
 
Creatinine clearance 
Present Absent <60 ml/min >60 ml/min 
No % No % No % No % 
Normal 38 6 15.8% 32 84.2% 11 28.9% 27 71.1% 
Grade 1 8 3 37.5% 5 62.5% 2 25% 6 75% 
Grade 2 9 5 55.6% 4 44.4% 6 66.7% 3 33.3% 
Grade 3 & 4* 5 4 80% 1 20% 4 80% 1 20% 
Chi Square 12.62 8.7 
p-value 0.005 0.03 
                       *Stage 3 &4 are combined for statistical analysis 
 
Parameters 
Microalbuminuria 
(>30mg/d) 
‘t’ 
value 
‘p’ 
Value 
Creatinine clearance 
(< 60 ml/min) 
‘t’ 
value 
‘p’ 
Value 
Present Absent Present Absent 
Age  
(years) 
53.89 ± 
5.603 
48.55 ± 9.508 2.217 0.031 53.52 ± 6.473 48.05 ± 
9.507 
2.427 0.018 
Duration 
(years ) 
10.39 ± 
5.066 
5.10 ± 3.906 4.392 0.000 10.09 ± 5.187 4.57 ± 
3.296 
5.049 0.000 
Systolic BP 
(mm/Hg) 
170.78 ± 
22.66 
153.5 ± 19.45 2.987 0.004 165.6 ± 19.924 154.4 ± 
22.026 
1.988 0.052 
Diastolic BP 
(mm/Hg) 
101.7 ± 
12.017 
91.19 ± 10.284 3.473 0.001 97.57 ± 11.801 92.57 ± 
11.497 
1.682 0.098 
RBS  
(mg/dl) 
91.40 ± 
18.023 
101.4 ± 20.641 1.783 0.08 92.57 ± 19.635 102.02 ± 
20.07 
1.788 0.079 
Sr creatinine  
(mg/dl ) 
1.139 ± 
0.1501 
0.869 ± 0.194 5.247 0.000 1.130 ± 0.838 0.838 ± 
0.1785 
6.562 0.000 
Creatinine 
Clearance 
(ml/min) 
60.54 ± 
13.246 
87.75 ± 26.25 4.161 0.000 54.48 ± 4.298 95.19 ± 
21.525 
8.941 0.000 
24 hrs Urine 
albumin (mg/d) 
92.92 ± 
35.735 
13.35 ± 6.315 14.07 0.000 64.33 ± 50.726 20.37 ± 
23.032 
4.583 0.000 
Total Cholesterol 
(mg/dl) 
219.9 ± 
70.722 
184.1 ± 31.012  2.247 0.008 198.6 ± 34.466 192.5 ± 
56.253 
0.472 0.639 
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Out of the total 60 patients, 28 patients had mild renal 
dysfunction (46%) and 32 patients had presence of TOD (53%).  
Retinopathy in this study was observed in 22 subjects (36.6%). 
But out of the 18 subjects who had urine microalbumin present, 
12 subjects had the presence of hypertensive retinopathy (66%, 
p0.001). In 23 subjects with reduced creatinine clearance, 
retinopathy was found in 12 subjects (52%, p <0.049). Also, 
increasing severity of hypertensive retinopathy grades was 
associated with increasing incidence of microalbuminuria (p 
0.005) and reduced creatinine clearance (p <0.03) (Table 2). 
Left ventricular hypertrophy (LVH) detectable by both ECG and 
2D ECHO was seen in 21 out of 60 patients (35%). Out of 18 
Subjects with presence of urine microalbumin, 15 had LVH 
(83%, p<0.001). Again, 14 out of 23 subjects (60%, p <0.002) 
with reduced creatinine clearance had LVH. Of the remaining 
39 cases who had no LVH, only 3 (7.7%) where positive for 
microalbuminuria and 9 (23.1%) had a creatinine clearance <60 
ml/min/1.73m2. 
Reduced creatinine clearance (p<0.001), left ventricular 
hypertrophy (p<0.001), and retinopathy (p<0.001) was 
significantly higher in patients with microalbuminuria. 
Similarly, the proportion of microalbuminuria (p<0.001), left 
ventricular hypertrophy (p<0.002) and retinopathy (0.049) was 
found statistically significantly higher in patients with CCR<60 
ml/min (Figures 1, 2 & 3). 
 
Figure 1. LVH with Microalbuminuria and Creatinine 
Clearance 
 
          Figure 2. Target Organ Damage and Creatinine 
Clearance Rate 
 
Figure 3. Target Organ Damage and microalbuminuria 
A urine albumin level of more than 36 mg/day (p <0.001) was 
associated with increased incidence LVH (Figure 4) 
[Sensitivity–71.4(95% CI- 47.8 - 88.7), Specificity – 94.9 (95% 
CI- 82.7 - 99.4)] and more than 25 mg/day (p<0.0052) was 
associated with increased incidence retinopathy (Figure 5) 
[Sensitivity–59.1(95% CI- 36.4 - 79.3), Specificity – 84.2(95% 
CI- 68.7 - 94.0)].  
A creatinine clearance of less than 63 ml/min (p<0.0023)was 
associated with increased incidence LVH (Figure 6) 
[Sensitivity–71.4 (95% CI- 47.8 - 88.7), Specificity – 76.9 (95% 
CI- 60.7 - 88.9)] and  increased incidence of retinopathy (p 
0.009) when creatinine clearance was less than 67.1 ml/min  
(Figure 7) [Sensitivity–68.2 (95% CI- 45.1 - 86.1), Specificity – 
68.4 (95% CI- 51.3 - 82.5)]. 
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Figure 4. ROC curve for microalbuminuria and Left 
ventricular hypertrophy  
Area under the ROC curve (AUC) 0.835 
Standard Errora 0.0577 
95% Confidence intervalb 0.716 to 0.918 
z statistic 5.797 
Significance level P (Area=0.5) <0.0001 
a DeLong et al., 1988, b Binomial exact 
 
Figure 5. ROC curve for Microalbuminuria and 
Hypertensive Retinopathy 
Area under the ROC curve (AUC)  0.705 
Standard Errora 0.0734 
95% Confidence intervalb 0.573 to 0.816 
z statistic 2.796 
Significance level P (Area=0.5) 0.0052 
 a DeLong et al., 1988 
 b Binomial exact 
  
Figure 6. ROC curve for creatinine clearance and Left 
ventricular hypertrophy 
Area under the ROC curve (AUC) 0.721 
Standard Errora 0.0725 
95% Confidence intervalb 0.590 to 0.829 
z statistic 3.049 
Significance level P (Area=0.5) 0.0023 
 a DeLong et al., 1988  b Binomial exact 
 
 
 
 
 
 
 
 
Figure 7. ROC curve for creatinine clearance and 
hypertensive retinopathy 
Area under the ROC curve (AUC)  0.711 
Standard Errora 0.0707 
95% Confidence intervalb 0.579 to 0.820 
z statistic 2.978 
Significance level P (Area=0.5) 0.0029 
 a DeLong et al., 1988,   
b Binomial exact 
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DISCUSSION  
The results of the study show heavy burden of the disease in 
these asymptomatic subjects as 53% of subjects were found to 
have TOD. To our knowledge this was the first study to evaluate 
the relationship of both urine microalbumin and creatinine 
clearance with TOD in asymptomatic hypertensive Indian 
population. This study showed that relatively mild degrees of 
renal dysfunction i.e. presence of urine microalbumin or 
reduced creatinine clearance was associated with increased 
cardiovascular damage in the form of LVH or retinopathy. LVH 
was the most prevalent TOD followed by hypertensive 
retinopathy. In addition, TOD was more prevalent in 
hypertensive males than in females. Studies involving different 
population have shown similar high rates of TOD.[8,9,10,11] 
Hypertensive subjects found to have a UA > 30 mg/d in this 
study was at 30 times more risk developing subclinical target 
organ damage [95% CI: 3.6-253,p 0.001]. Similarly if the 
creatinine clearance was less than 60 ml/min/1.73m2, there was 
5.9 times more risk of developing subclinical target organ 
damage [95% CI: 1.7-19.4, p 0.0035]. But in those patients who 
were positive for both combined urine microalbumin and 
reduced creatinine clearance the risk was much higher than 
either one of them alone i.e. 39.4 times more risk of developing 
subclinical target organ damage  [95% CI: 2.2-703, p 0.0124]. 
This finding shows that a combined effect of microalbuminuria 
and reduced creatinine clearance is synergistic in increasing risk 
for target organ damage and hence would invariably have an 
effect on prognosis also. There is increasing evidence that a 
combination of two when present have a grave prognosis than 
either of them alone. This is shown in studies by Leoncini G [12] 
et al (2004), Viazzi F [13] et al (2010) , Salles GF [14] et al (2011).      
The results of the present study are in concurrence with various 
previous studies observing that presence of mild renal 
dysfunction was associated with subclinical TOD and an 
increased cardiovascular mortality.  
It has been well established that patients in end-stage renal 
disease had a high cardiovascular mortality. But recently, a mild 
reduced creatinine clearance as a risk factor for cardiovascular 
mortality and morbidity has been gaining traction. Although 
various studies showed that a high normal creatinine was an 
independent and equally important marker of cardiovascular 
events, it was Fried LP et al [15] who showed that a decrease of 
GFR < 70 ml/min resulted in a progressive increase of 3 year 
mortality from cardiovascular events. Later in the HOT study [16] 
a reduced creatinine clearance <60 ml/min was associated with 
3.2 times greater incidence of fatal events. The subsequent 
HOORN study [17] observed a fourfold risk of cardiovascular 
death when GFR decreased from 90 to 60ml/min. Recent studies 
by Leonicini G [12] and Das SK [18] has shown similar association 
between reduced creatinine clearance and TOD in subclinical 
hypertensive patients with normal creatinine.  
Overt albuminuria has been long associated with cardiovascular 
mortality and morbidity both in diabetic and non diabetic 
populations. After the concept of microalbuminuria by Keen in 
1960, studies have proved it as a reliable maker of generalized 
vascular endothelial dysfunction establishing its role as an 
indicator of early target organ damage in hypertensive patients. 
The PREVENT study [19] showed that microalbuminuria in 
hypertensive subjects was independently associated with 
myocardial ischemia and infarction. The MAGIC study [20] 
showed that those hypertensive patients with microalbuminuria 
had LVH and an increase risk of hypertensive retinopathy, acute 
coronary syndrome, arthrosclerosis and stroke. Recently a meta-
analysis of 1 million subjects has shown that an increasing 
microalbuminuria was associated with increase in deaths from 
all cause in a continuous manner with no threshold effect.    
Left ventricular hypertrophy seen in hypertensive patients as a 
result of mechanical stress and neurohormonal mechanisms is a 
reliable marker of TOD. LVH was present in 21 subjects 
(35%).In subjects with CCR < 60 ml/min vs CCR > 60 ml/min 
the percentage of LVH was 60% vs 18%(p 0.002). Similar 
results were shown by Das SK [18] (55% VS 20%, p.001) and 
Giovanna Leoncini [12] et al (71% VS 42%, p= 0.0001). In 
subjects with UA > 30 mg/d vs UA< 30 mg/d the percentage of 
LVH was 83% vs 14%.(p<0.001). Similar results seen with Das 
SK (78.57% vs 15.38%, p= .000) but lower percentages were 
seen with Kirsten [21] (30% vs 9%, p<0.001). The significance of 
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this is that in patients with left ventricular hypertrophy 
(especially the concentric type) there was a higher risk of 
developing a coronary event or a destroke as compared to those 
with normal left ventricular geometry.[22] 
Hypertensive retinopathy was present in 22 subjects (36%). This 
was similar to the hypertensive retinopathies observed by 
Ghanshyam et al [23] at 38%. In our study we observed UA > 30 
mg/d increased the risk of of retinopathy by 6.4 times. In 
subjects with UA > 30 mg/d vs UA<30 mg/d the percentage of 
retinopathy were 66% vs 23% (p 0.001). Ghanshyam et al got 
slightly higher percentage (78.1% vs 14.5, p <0.001). 
Retinopathy was found in 52% of subjects with CCR < 
60ml/min while it was present in only 27% subjects with normal 
CCR (p < 0.049).    
In this study, we found negative significant correlation between 
microalbuminuria and CCR clearance (r -0.498 , p < 0.001). This 
finding is consistent with results observed by Das 
 SK18 (r -0.314, p 0.004) and De La Sierra et al [24] who showed 
a serum creatinine >88 pmol/L (odds ratio:3.08; CI 95%: 1.39-
6.84) was independently associated with increased urinary 
albumin excretion. 
The importance of our study is that as the prevalence of 
hypertension, a life style modifiable disease in India is expected 
to rise with increasing urbanisation, so is the burden of the 
comorbidities even in asymptomatic hypertensive patients ( 
53% in the present study). In our study there has been a strong 
association between reduced creatinine clearance, 
microalbumin and the presence of LVH or retinopathy. The 
development of subclinical cardiovascular damage, such as 
hypertensive retinopathy and/or LVH,[25] often precedes and 
predicts the acute onset of major events and has proven to be a 
powerful independent predictor of cardiovascular prognosis.[26] 
The association of various risk factors in this study with both 
MA and CCR in part explains the finding of TOD even thought 
they were asymptomatic. These traditional risk factors in 
association with uncontrolled hypertension caused unfavourable 
functional and structural organ changes along with the 
acceleration of development of atherosclerosis resulting in TOD 
in these subjects.  Both MA and CCR<60ml/min were 
associated with an unfavourable lipid profile (p< 0.001 & 
p<0.001) and increasing duration of the disease (p<0.004 & 
p<0.001). But microalbuminuria had additional significant 
association with BMI (p<0.05) and severity of SBP/DBP 
(p<0.002). As a result of these associated risk factors being more 
for MA, our study showed that MA predicted TOD more 
significantly than a CCR< 60 ml/min at 30 times (p<0.001) vs 
5.9 times (p<0.003).         
CONCLUSION 
Although preventing target organ damage is more important 
than treating it, with the help of these renal markers early 
detection of organ damage in these asymptomatic hypertensive 
subjects can be aimed for. This will in turn result in a tighter 
control of BP so as to aid in regression of the organ damage and 
improve the overall prognosis. A wider application of these tests 
could significantly improve the cost-effectiveness of the 
diagnostic approach in patients with hypertension. This may 
lead to a substantial improvement in identifying high risk 
patients while optimizing the cost effectiveness of CV risk 
stratification. 
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